Skip to main content
. 2022 Aug 4;12:985470. doi: 10.3389/fonc.2022.985470

Figure 8.

Figure 8

MiR-625 sensitizes the response to paclitaxel by regulating ZEB2 in endometrial cancer cells. (A) Endometrial cancer cells were transfected as indicated and treated with various concentrations of Paclitaxel, and cell viability was determined using a CCK-8 assay. (B) Western blot assay of ZEB2 and actin expression in endometrial cancer cells transfected as indicated. (C) Endometrial cancer cells were transfected as indicated and treated with various concentrations of Paclitaxel, and cell viability was determined using a CCK-8 assay. ***P < 0.001.